Skip to content
ClosedNo longer accepting applications

Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31

VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.260-NETWORK CONTRACT OFFICE 20 (36C260)

This opportunity closed July 10, 2026. 5 similar opportunities are open right now.

About this archived opportunity

The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies. MRD is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL).

Historical details

Status
Closed
Deadline
July 10, 2026
First captured
July 3, 2026
Publisher reference
7fb96aee1d3343b6abc52b20a4be4109

Free. One email, sent if this program reopens or a close match to it opens. We watch for 12 months, then stop. No list.

Refine this search